Enantiomeric screening of racemic citalopram and metabolites in human urine by entangled polymer solution capillary electrophoresis: An innovatory robustness/ruggedness study

Electrophoresis

Volumn 27, Issue 4, 2006, Pages 905-917

  Berzas Nevado, Juan José ^a   Vellaseñor Llerena, María Jesús ^a   Rodríguez Robledo, Virginia ^a  

^a UNIVERSITY OF CASTILLA LA MANCHA   (Spain)

Author keywords

Chiral capillary electrophoresis; Citalopram; Cyclodextrin; Enantiomers; Entangled polymer solution; Metabolites

Indexed keywords

BIOMOLECULES; BODY FLUIDS; CAPILLARY ELECTROPHORESIS; CHIRALITY; ENANTIOMERS; PROPIONIC ACID; STEREOCHEMISTRY;

CARBOXYMETHYL; CHIRAL CAPILLARY ELECTROPHORESIS; CITALOPRAM; ENANTIOMERICS; ENTANGLED POLYMER SOLUTIONS; HUMAN URINE; HUMAN URINE SAMPLES; HYDROXYPROPYL METHYLCELLULOSE; RACEMIC CITALOPRAM; Γ-CD;

METABOLITES;

BUFFER; CARBOXYMETHYL GAMMA CYCLODEXTRIN; CITALOPRAM; CITALOPRAM N OXIDE; CITALOPRAM PROPIONIC ACID; CYCLODEXTRIN; DINORCITALOPRAM; DRUG METABOLITE; HYDROXYPROPYLMETHYLCELLULOSE; NORCITALOPRAM; PHOSPHATE; POLYMER; PRISDAL; UNCLASSIFIED DRUG;

ACCURACY; ANALYTIC METHOD; ARTICLE; CAPILLARY ELECTROPHORESIS; CHEMICAL PARAMETERS; CHIRALITY; DRUG ISOLATION; DRUG SCREENING; DRUG STRUCTURE; DRUG URINE LEVEL; ELECTRIC POTENTIAL; ENANTIOSELECTIVITY; HUMAN; IONIC STRENGTH; LINEAR SYSTEM; RACEMIC MIXTURE; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STEREOCHEMISTRY; TEMPERATURE; URINALYSIS; VALIDATION PROCESS;

EID: 33644746277     PISSN: 01730835     EISSN: 15222683     Source Type: Journal    
DOI: 10.1002/elps.200500413     Document Type: Article

References (34)

1. Baumann, P., Int. Clin. Psychopharmacol. 1996, 11, 5-11.
2. Goodnick, P. J., Goldstein, B. J., J. Psychopharmacol. 1998, 12, 5-20.
3. Kragh-Sorensen, P., Fredricson Overø, K., Peterson, O. L., Jensen, K., Parnas, W., Acta Pharmacol. Toxicol. 1981, 48, 53-60.
4. Fredricson Overø, K., Prog. Neuro-Psychopharmacol. Biol. Psych. 1982, 6, 311-318.
5. Hyttel, J., Prog. Neuro-Psychopharmacol. Biol. Psych. 1982, 6, 277-295.
6. Oyehaug, E., Ostensen, E. T., J. Chromatogr. 1984, 308, 199-208.
7. Raggi, M. A., Pucci, V., Mandrioli, R., Sabbioni, C., Fanali, S., Chromatographia 2003, 57, 273-278.
8. Carlsson, B., Olsson, G., Reis, M., Walinder, J., et al., Ther. Drug Monit. 2001, 23, 658-664.
9. Carlsson, B., Norlander, B., J. Chromatogr. B 1997, 702, 234-239.
10. Carlsson, B., Norlander, B., Chromatographia 2001, 53, 266-272.
11. Zheng, Z. C., Jamour, M., Klotz, U., Ther. Drug Monit. 22 2000, 219-224.
12. Kosel, M., Eap, C. B., Amey, M., Baumann, P., J. Chromatogr. B 1998, 719, 234-238.
13. Rochat, B., Amey, M., Van-Gelderen, H., Testa, B., Baumann, P., Chirality 7 1995, 389-395.
14. Reymond, P., Amey, M., Souche, A., Lambert, S., et al., J. Chromatogr. Biomed. Appl. 1993, 616, 221-228.
15. Amini, A., Electrophoresis 2001, 22, 3107-3130.
16. Chankvetadze, B., Blaschke, G., J. Chromatogr. A 2001, 906, 309-363.
17. Fanali, S., J. Chromatogr. A 2000, 875, 89-122.
18. Fillet, M., Hubert, P., Crommen, J., J. Chromatogr. A 2000, 875, 123-134.
19. Matthijs, N., Perrin, C., Maftouh, M., Massart, D. L., Heyden, Y. V., J. Pharm. Biomed. Anal. 2002, 27, 515-529.
20. Zaugg, S., Thormann, W., J. Chromatogr. A 2000, 875, 27-41.
21. Mandrioli, R., Fanali, S., Pucci, V., Raggi, M. A., Electrophoresis 2003, 24, 2608-2616.
22. Bae, Y., Soane, D., J. Chromatogr. 1993, 652, 17-22.
23. Chin, A., Colburn, J., Am. Biotech. Lab. 1989, 7, 16.
24. Grossman, P., Soane, D., Biopolymers 1991, 31, 1221-1228.
25. Quang, C., Khaledi, M., Anal. Chem. 1993, 65, 3354-3358.
26. Nielen, M., Anal. Chem. 1993, 65, 885-893.
27. Berzas, J., Guiberteau, C., Villaseñor, M., Rodríguez, V., J. Chromatogr. A 2005, 1072, 249-257.
28. ICH Guidance for Industry: Q2B Text on Validation of Analytical Procedures, US Department of Health and Human Services, Foods and Drugs Administration, CDER, Rockville, USA 1996.
29. Altria, K. D., Chromatographia 1993, 35, 177-182.
30. Amc technical brief, Analytical Methods Committee, The Royal Society of Chemistry 2000, p. 200.
31. National Formulary 18, United States Pharmacopeia Convention, The United Stated Pharmacopeia (23rd edn.), Rockville, USA 1995.
32. Plackett, R. L., Burman, J. P., Biometrika 1946, 33, 305-325.
33. "Validation of compendial methods" USP 23, 1225; USPC, Rockville, Maryland, USA 1994.
34. Huber, L., Applications of diode-array experience, Hewlett Packard, 1989, Publication no. 12-5953-2330.